. 2014 Nov 19;7(2):76–82. doi: 10.14740/jocmr1996w

Table 1. Effects of PL-ES or PL-I-ES on Caspase Activity.

Cancer cells (controls)	PL-ES (100 µg/mL)		PL-I-ES (250 µg/mL)
Cancer cells (controls)	Csp-3	Csp-9	Csp-3	Csp-9
PC-3 (1.0)^a	3.0	3.4	3.5	4.2
DU-145 (1.0)^a	3.5	4.4	1.2^b	1.3^b
LNCaP (1.0)^a	2.9	3.3	1.5^b	1.6^b
T24 (1.0)^a	3.3	4.2	3.2	3.9
ACHN (1.0)^a	2.6	3.0	1.1^b	1.3^b
A549 (1.0)^a	2.8	3.3	2.5	2.9
MCF-7 (1.0)^a	3.4	4.2	3.3	4.0
AGS (1.0)^a	2.9	3.2	2.9	3.5
HepG2 (1.0)^a	3.4	4.3	3.7	4.5
U-87 (1.0)^a	2.8	3.1	2.3	2.6

^aA value of 1.0 in parenthesis indicates an arbitrary number set for activity of caspase-3 (Csp-3) and caspase-9 (Csp-9) in control or untreated cells, following the results of enzymatic assays. ^bP > 0.05 (differences are not significant compared to controls).